Table 1. Baseline patient characteristics at time of ART initiation.

Patients (n)	Total population (n = 244)	Controls (n = 200)	Failures (n = 44)	p-values
Age: years	32 (28–37)	32 (28–38)	31 (27–34)	0.0642
Female: n (%)	180 (73.8%)	147 (73.5%)	33 (75.0%)	0.838
WHO Stage: n (%)
Stage III	127 (52.1%)	107 (53.5%)	20 (45.5%)	0.343
Stage IV	67 (27.5%)	51 (25.5%)	16 (36.4%)
CD4 cell count (cells/µL)	108 (56–152)	115 (69–156)	49 (15–103)	<0.001
HIV-1 Viral Load, log10 copies/mL	4.82 (4.48–5.23)	4.78 (4.43–5.22)	5.00 (4.68–5.52)	0.041

Values are given as median (IQR), unless otherwise stated.